Shares of BioScrip, Inc. (NASDAQ:BIOS) have moved 145.19% so far in 2017 and they are now -8.60% from where the price during the same period last year.
Over the past six months the shares price has moved 145.19%, while it has moved 44.07% over the previous quarter. Over the last week and the past one month, the shares price has moved 4.94% and 48.26%, respectively.
The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend. The market is in highly overbought territory. Beware of a trend reversal.
Recently, BioScrip, Inc. (NASDAQ:BIOS) stated that studying the technical demonstrates its 20-Day Simple Moving Average is $18.47% and 50-Day Simple Moving Average is $40.89% while 200-Day Simple Moving Average is $35.44%.
The stock has dropped to a low of $88.89% over the previous 50 days and made a high of $-1.16% over the same period. Though, the stock’s price range in the previous 12 months is a high of $-25.66% and a low of $160.20%.
Analysts following BioScrip, Inc. have a mean recommendation of 1.70 on its stock. Recommendation of 1 indicates STRONG BUY, 3 shows HOLD and 5 indicates SELL.
The stock is trading around $2.55, but it should be trading around $2.75 by the close of the next 12 months as per the analysts.
The equity’s average volume, which is the mean of three months, is 1.46M, while its relative volume is 0.45.
Insiders own 0.50% of BioScrip, Inc., while institutional investors hold 87.30% of the company.
Of the firm’s 120.51M shares due, 120.49M are free float. Of the floating shares, 19.40% are sold short, which brings short ratio to 16.02.
BioScrip, Inc. posted EPS for the preceding fiscal year and the ongoing year’s EPS is projected to increase 89.80% over the previous year’s EPS.
The firm’s next earnings date is planned for May 04/b.